基于查尔斯的动态名图,用于预测中年和老年人的抑郁风险
Yang Tan1, Wen-Hai Zhang2, Zi-Hao Liu3
1Department of Pathology, Liuzhou People's Hospital/Liuzhou People's Hospital affiliated to Giangxi Medical University, No. 8 WenChang Road, Liuzhou, 530000, Guangxi Zhuang Autonomous Region, China.
Scientific reports
|October 10, 2025
概括
这项研究开发了一种名谱,以利用健康和生活方式因素预测老年人抑郁风险. 该模型显示了良好的准确性,有助于早期查和抑郁症的干预.
科学领域:
- 老年学是指老年学的学科.
- 精神病学是一个精神病学.
- 生物统计学 生物统计学
背景情况:
- 抑郁症是中年和老年人群的重大健康问题.
- 准确的风险评估对于及时干预和管理至关重要.
- 现有的预测模型可能缺乏针对不同人口群体的具体适用性.
研究的目的:
- 开发和验证基于名录的风险评估模型,用于预测患有抑郁症的高风险个体.
- 确定中年和老年人群中抑郁症的关键预测因素.
- 通过交互式的动态网络应用程序来增强临床实用性.
主要方法:
- 利用中国健康与退休纵向研究 (CHARLS) 的数据进行培训和验证队列.
- 使用斯皮尔曼相关性,LASSO和特征选择的回归分析.
- 使用校准曲线,ROC曲线和决策曲线分析评估模型性能.
主要成果:
- 该名录包括性别,酒精消费,自我评估的健康状况,生活满意度,睡眠障碍,ADL得分,认知,听力和疼痛.
- 获得的AUC值为0.823 (培训),0.823 (内部验证) 和0.819 (外部验证).
- 证明了良好的校准和临床实用性,由交互式网络工具支持.
结论:
- 开发的诺米图谱是预测老年人抑郁风险的有效工具.
- 该模型为早期查提供了良好的预测性能和临床实用性.
- 促进早期干预,有可能减少这一人口群体的抑郁负担.
更多相关视频
相关概念视频
Dosage Regimen Designs: Nomograms and Tabulations
179
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
179
Depressive Disorders: MDD and Dysthymia
649
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
649
Depression: Overview
781
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
781
Depressive Disorders: Etiology
441
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
441
Diagnostic and Statistical Manual of Mental Disorders (DSM)
1.1K
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
1.1K
Pharmacodynamics in Geriatric Patients: Effects of Age
187
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
187


